A price comparison of recently launched proprietary pharmaceuticals in the UK and the US.

J Mark Access Health Policy · 2016 · PMC5023951 · PMID 27695606

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an overall trendno p-value reported

It is important to highlight that, given the overlapping CIs across the different therapy groupings analysed here, the results presented should only be interpreted as an overall trend.

also in 4,871 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.